314 related articles for article (PubMed ID: 9925781)
1. Folding and assembly of an antibody Fv fragment, a heterodimer stabilized by antigen.
Jäger M; Plückthun A
J Mol Biol; 1999 Feb; 285(5):2005-19. PubMed ID: 9925781
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment.
Arndt KM; Müller KM; Plückthun A
Biochemistry; 1998 Sep; 37(37):12918-26. PubMed ID: 9737871
[TBL] [Abstract][Full Text] [Related]
3. The scFv fragment of the antibody hu4D5-8: evidence for early premature domain interaction in refolding.
Jäger M; Gehrig P; Plückthun A
J Mol Biol; 2001 Feb; 305(5):1111-29. PubMed ID: 11162118
[TBL] [Abstract][Full Text] [Related]
4. The rate-limiting steps for the folding of an antibody scFv fragment.
Jäger M; Plückthun A
FEBS Lett; 1997 Nov; 418(1-2):106-10. PubMed ID: 9414105
[TBL] [Abstract][Full Text] [Related]
5. Domain interactions in antibody Fv and scFv fragments: effects on unfolding kinetics and equilibria.
Jäger M; Plückthun A
FEBS Lett; 1999 Dec; 462(3):307-12. PubMed ID: 10622716
[TBL] [Abstract][Full Text] [Related]
6. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
Wörn A; Plückthun A
Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
[TBL] [Abstract][Full Text] [Related]
7. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
Tan PH; Sandmaier BM; Stayton PS
Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
[TBL] [Abstract][Full Text] [Related]
8. Direct evidence by H/D exchange and ESI-MS for transient unproductive domain interaction in the refolding of an antibody scFv fragment.
Jäger M; Plückthun A
Protein Sci; 2000 Mar; 9(3):552-63. PubMed ID: 10752617
[TBL] [Abstract][Full Text] [Related]
9. Parallel pathways in the folding of a short-term denatured scFv fragment of an antibody.
Freund C; Gehrig P; Baici A; Holak TA; Plückthun A
Fold Des; 1998; 3(1):39-49. PubMed ID: 9502319
[TBL] [Abstract][Full Text] [Related]
10. Removal of the conserved disulfide bridges from the scFv fragment of an antibody: effects on folding kinetics and aggregation.
Ramm K; Gehrig P; Plückthun A
J Mol Biol; 1999 Jul; 290(2):535-46. PubMed ID: 10390351
[TBL] [Abstract][Full Text] [Related]
11. A kinetic trap is an intrinsic feature in the folding pathway of single-chain Fv fragments.
Hoyer W; Ramm K; Plückthun A
Biophys Chem; 2002 May; 96(2-3):273-84. PubMed ID: 12034446
[TBL] [Abstract][Full Text] [Related]
12. Expression and characterization of recombinant single-chain Fv and Fv fragments derived from a set of catalytic antibodies.
Kim SH; Schindler DG; Lindner AB; Tawfik DS; Eshhar Z
Mol Immunol; 1997; 34(12-13):891-906. PubMed ID: 9464525
[TBL] [Abstract][Full Text] [Related]
13. Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment.
Nieba L; Honegger A; Krebber C; Plückthun A
Protein Eng; 1997 Apr; 10(4):435-44. PubMed ID: 9194169
[TBL] [Abstract][Full Text] [Related]
14. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
15. Structural and dynamic properties of the Fv fragment and the single-chain Fv fragment of an antibody in solution investigated by heteronuclear three-dimensional NMR spectroscopy.
Freund C; Ross A; Plückthun A; Holak TA
Biochemistry; 1994 Mar; 33(11):3296-303. PubMed ID: 8136365
[TBL] [Abstract][Full Text] [Related]
16. Efficient construction of a diabody using a refolding system: anti-carcinoembryonic antigen recombinant antibody fragment.
Asano R; Kudo T; Nishimura Y; Makabe K; Hayashi H; Suzuki M; Tsumoto K; Kumagai I
J Biochem; 2002 Dec; 132(6):903-9. PubMed ID: 12473192
[TBL] [Abstract][Full Text] [Related]
17. Folding nuclei of the scFv fragment of an antibody.
Freund C; Honegger A; Hunziker P; Holak TA; Plückthun A
Biochemistry; 1996 Jun; 35(25):8457-64. PubMed ID: 8679604
[TBL] [Abstract][Full Text] [Related]
18. V
Fernández-Quintero ML; Hoerschinger VJ; Lamp LM; Bujotzek A; Georges G; Liedl KR
Proteins; 2020 Jul; 88(7):830-839. PubMed ID: 31904133
[TBL] [Abstract][Full Text] [Related]
19. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.
Röthlisberger D; Honegger A; Plückthun A
J Mol Biol; 2005 Apr; 347(4):773-89. PubMed ID: 15769469
[TBL] [Abstract][Full Text] [Related]
20. Cyclization of Single-Chain Fv Antibodies Markedly Suppressed Their Characteristic Aggregation Mediated by Inter-Chain VH-VL Interactions.
Yamauchi S; Kobashigawa Y; Fukuda N; Teramoto M; Toyota Y; Liu C; Ikeguchi Y; Sato T; Sato Y; Kimura H; Masuda T; Ohtsuki S; Noi K; Ogura T; Morioka H
Molecules; 2019 Jul; 24(14):. PubMed ID: 31323851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
